RCUS insider buying and SEC filings, explained
Arcus Biosciences, Inc. · CIK 1724521
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$11.5M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 21, 2026 | Planned (10b5-1) | Alexander Azoy (Chief Accounting Officer) sold 2,827 shares at $30.00 ($85K), marked as a 10b5-1 plan trade. Holdings down 7% to 39,581 shares. | SEC filing Filed Aug 24, 2026 |
| Jul 9–10, 2026 | Planned (10b5-1) | Juan C. Jaen (President / COO) sold 68,569 shares indirectly (by trust) between Jul 9 and Jul 10 at about $29.63 ($2.0M), marked as a 10b5-1 plan trade. Holdings by trust down 8% to 822,240 shares. | SEC filing Filed Jul 13, 2026 |
| Jun 22–24, 2026 | Planned (10b5-1) | Juan C. Jaen (President / COO) sold 31,431 shares indirectly (by trust) between Jun 22 and Jun 24 at about $27.92 ($878K), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 890,809 shares. | SEC filing Filed Jun 24, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Alexander Azoy (Chief Accounting Officer) sold 2,562 shares at about $25.77 ($66K), marked as a 10b5-1 plan trade. Holdings down 6% to 39,581 shares. | SEC filing Filed Jun 1, 2026 |
| May 11, 2026 | Planned (10b5-1) | Robert C. Goeltz II (CFO) sold 7,763 shares at $25.63 ($199K), marked as a 10b5-1 plan trade. Holdings down 8% to 84,161 shares. | SEC filing Filed May 12, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Juan C. Jaen (President / COO) sold 31,823 shares indirectly (by trust) at about $21.41 ($681K), marked as a 10b5-1 plan trade. Holdings by trust down 3% to 922,240 shares. | SEC filing Filed Jan 7, 2026 |
| Dec 31, 2025 | Planned (10b5-1) | Robert C. Goeltz II (CFO) sold 6,552 shares at $23.38 ($153K), marked as a 10b5-1 plan trade. Holdings down 9% to 67,924 shares. | SEC filing Filed Jan 2, 2026 |
| Dec 16–17, 2025 | Planned (10b5-1) | Richard Markus (Chief Medical Officer) sold 9,546 shares between Dec 16, 2025 and Dec 17, 2025 at about $22.01 ($210K), marked as a 10b5-1 plan trade. Holdings down 13% to 65,647 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 16–17, 2025 | Planned (10b5-1) | Carolyn C. Tang (General Counsel) sold 14,468 shares between Dec 16, 2025 and Dec 17, 2025 at about $22.01 ($318K), marked as a 10b5-1 plan trade. Holdings down 10% to 124,734 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 16–18, 2025 | Planned (10b5-1) | Alexander Azoy (Chief Accounting Officer) sold 8,832 shares between Dec 16, 2025 and Dec 18, 2025 at about $22.13 ($195K), marked as a 10b5-1 plan trade. Holdings down 32% to 18,531 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 16–17, 2025 | Planned (10b5-1) | Jennifer Jarrett (President / COO) sold 21,208 shares between Dec 16, 2025 and Dec 17, 2025 at about $22.01 ($467K), marked as a 10b5-1 plan trade. Holdings down 10% to 193,024 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 16–17, 2025 | Planned (10b5-1) | Robert C. Goeltz II (CFO) sold 12,662 shares between Dec 16, 2025 and Dec 17, 2025 at about $22.01 ($279K), marked as a 10b5-1 plan trade. Holdings down 15% to 74,476 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 16–17, 2025 | Planned (10b5-1) | Juan C. Jaen (President / COO) sold 21,208 shares between Dec 16, 2025 and Dec 17, 2025 at about $22.01 ($467K), marked as a 10b5-1 plan trade. Holdings down 6% to 346,012 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 16–17, 2025 | Planned (10b5-1) | Terry J. Rosen (CEO and Director) sold 54,691 shares between Dec 16, 2025 and Dec 17, 2025 at about $22.01 ($1.2M), marked as a 10b5-1 plan trade. Holdings down 2% to 2,194,809 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 4, 2025 | Planned (10b5-1) | Juan C. Jaen (President / COO) sold 82,997 shares indirectly (by trust) at about $24.71 ($2.1M), marked as a 10b5-1 plan trade. Holdings by trust down 8% to 954,063 shares. | SEC filing Filed Dec 5, 2025 |
| Nov 26, 2025 | Planned (10b5-1) | Alexander Azoy (Chief Accounting Officer) sold 1,900 shares at $26.00 ($49K), marked as a 10b5-1 plan trade. Holdings down 6% to 27,363 shares. | SEC filing Filed Dec 1, 2025 |
| Nov 26, 2025 | Planned (10b5-1) | Robert C. Goeltz II (CFO) sold 5,000 shares at $25.00 ($125K), marked as a 10b5-1 plan trade. Holdings down 5% to 87,138 shares. | SEC filing Filed Nov 26, 2025 |
| Nov 17–18, 2025 | Planned (10b5-1) | Juan C. Jaen (President / COO) sold 50,000 shares indirectly (by trust) between Nov 17, 2025 and Nov 18, 2025 at about $20.26 ($1.0M), marked as a 10b5-1 plan trade. Holdings by trust down 5% to 1,037,060 shares. | SEC filing Filed Nov 19, 2025 |
| Nov 7, 2025 | Planned (10b5-1) | Jennifer Jarrett (President / COO) sold 50,291 shares at about $18.97 ($954K), marked as a 10b5-1 plan trade. Holdings down 19% to 214,232 shares. | SEC filing Filed Nov 12, 2025 |
| Oct 30, 2025 | Planned (10b5-1) | Juan C. Jaen (President / COO) sold 4,314 shares indirectly (by trust) at about $20.32 ($88K), marked as a 10b5-1 plan trade. Holdings by trust down <1% to 1,087,060 shares. | SEC filing Filed Nov 3, 2025 |
21 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow RCUS in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.